← Back to Search
Pathology Of Breast Cancer: From Classic Concepts To Molecular Pathology And Pathogenesis
Ilze Štrumfa, A. Vanags, A. Āboliņš, J. Gardovskis
Published 2012 · Medicine
Download PDFAnalyze on Scholarcy
Summary Breast cancer has high incidence and still significant mortality. Due to the widespread application and efficacy of surgery in breast cancer treatment, the surgeon has a crucial role in the treatment planning. Taking into account the tendency to personalized cancer care and the heterogeneity of breast cancer, the surgeon has to be aware about the prognostic and predictive characteristics of breast cancer. We discuss here the classaic pathology of breast cancer along with molecular subtypes, novel prognostic markers and molecular pathogenesis.
This paper references
The clonal evolution of tumor cell populations.
P. Nowell (1976)
The microenvironment in breast cancer progression: biology and implications for treatment
A. Place (2011)
Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.
J. Jackson (1997)
Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
M. Al-Alwan (2011)
Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer
A. Phipps (2008)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
L. Carey (2006)
MMP-1 expression has an independent prognostic value in breast cancer
Pia Boström (2011)
Adipocyte is a non-trivial, dynamic partner of breast cancer cells.
J. Tan (2011)
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J. Parker (2009)
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.
V. Guarneri (2009)
Connective tissue alterations in women with pelvic organ prolapse and urinary incontinence
Rafi Suzme (2007)
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
H. Buerger (1999)
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
D. Allred (2008)
The molecular pathology of breast cancer progression
A. Bombonati (2011)
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch (2011)
Epigenetics in breast cancer: what's new?
Yi Huang (2011)
The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
F. Reyal (2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
D. Iliopoulos (2011)
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
R. Aimes (1995)
Symptomatic Pelvic Organ Prolapse at Midlife, Quality of Life, and Risk Factors
X. Fritel (2009)
Breast cancer subtypes and the risk of local and regional relapse.
K. D. Voduc (2010)
Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: A rat patellar tendon model
B. Chan (2000)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
B. Weigelt (2010)
Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse
B. Gabriel (2005)
The Roles of Growth Factors in Tendon and Ligament Healing
T. Molloy (2003)
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
R. Natrajan (2009)
Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.
R. Roylance (1999)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
A. Prat (2010)
Invasive Breast Cancer: Recognition of Molecular Subtypes
J. Strehl (2011)
Stem cells, cancer, and cancer stem cells
T. Reya (2001)
Remodeling of Vaginal Connective Tissue in Patients With Prolapse
P. Moalli (2006)
Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis.
A. Ewies (2003)
Identification of molecular apocrine breast tumours by microarray analysis
P. Farmer (2005)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
M. Cheang (2009)
Changes in metabolism of collagen in genitourinary prolapse
S. Jackson (1996)
Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
Ju-Hee Kang (2011)
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.
T. Sørlie (2004)
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
Z. Gabos (2006)
Histological, molecular and functional subtypes of breast cancers
G. Malhotra (2010)
Molecular characterization of apoptosis by the immunohistochemical evaluation of Bcl-2 in breast cancer.
D. Zaha (2012)
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
T. Nielsen (2004)
Uterine prolapse: evaluation of glycosaminoglycans in postmenopausal women after estrogen therapy
J. C. Nunes (2011)
Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device
M. Carey (2008)
Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
J. Peppercorn (2008)
Changes of glycoprotein and collagen immunolocalization in the uterine artery wall of postmenopausal women with and without pelvic organ prolapse.
C. Goepel (2011)
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
T. Nielsen (2010)
p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
S. Wander (2010)
Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse
Petek Balkanlı Kaplan (2011)
This paper is referenced by
Association of BRCA 1 and BRCA 2 Protein Expression in Breast Cancers With Their Histological Phenotype by Immunohistochemistry in Indigenous Black Malawians Presenting at Queen Elizabeth Central Hospital
Nelson Chimbiya (2016)
Clinical and Pathological Characteristics of BRCA2 Positive Breast Cancer in Egyptian Female Patients
Taher Abdel-Aziz (2015)